# A Bioequivalence Study of Tobradex AF

> **NCT00362895** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 995 (actual)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Tobramycin 0.3% / Dexamethasone 0.033% ophthalmic suspension
- **DRUG:** Tobramycin 0.3% / Dexamethasone 0.1% ophthalmic suspension (TOBRADEX)

## Key facts

- **NCT ID:** NCT00362895
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 995 (ACTUAL)
- **Last updated:** 2012-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362895, "A Bioequivalence Study of Tobradex AF". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00362895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*